Novartis’s Fiona Marshall Says RLT Can Treat Nearly Every Tumor as Pipeline Tops 20 Candidates — BigGo Finance
A Platform Bet on Radiation The most consequential idea in Fiona Marshall’s vision for Novartis research is also…
Novartis’ Pluvicto unlocks substantial new patient pool
Novartis’ blockbuster radioligand therapy Pluvicto has cleared a key milestone on its quest to hit $5 billion in…
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population PSMAddition updated results show Pluvicto…
Novartis Launches Prostate Cancer Radiotherapy
The launch highlights the growing maturity of India’s nuclear medicine ecosystem. Kindly note that this illustration generated using…
Novartis charts next US investment with new radiopharma plant
As Novartis turns the calendar on a new year, the Swiss drugmaker is elaborating further on plans for…
Novartis CEO eyes 2026 growth despite record patent cliff
Novartis CEO Vas Narasimhan is doubling down on a growth forecast for 2026, even as the Swiss drugmaker’s…
Novartis details plan for 2nd new US radiopharma plant
Novartis is wasting little time sketching out the radiopharmaceutical details of its $23 billion U.S. investment push. Shortly…
Novartis stands by $5B Pluvicto goal despite EU regulatory setback
Novartis CEO Vas Narasimhan is doubling down on his $5 billion peak sales projection for Pluvicto, even as…
Novartis Introduces Pluvicto: Revolutionary Radioligand Therapy for Prostate Cancer in India, ETPharma
New Delhi: Swiss pharma major, Novartis has announced the commercial launch of its targeted radioligand therapy, Pluvicto (lutetium…
Novartis launches prostate cancer drug
New Delhi: Novartis India on Monday announced the launch of Pluvicto, a precision radiotherapy for prostate cancer. Pluvicto…
Novartis India launches Pluvicto for PSMA-positive metastatic prostate cancer
Novartis India launches Pluvicto for PSMA-positive metastatic prostate cancer – Express…
Advancing Precision Oncology Novartis Launches India’s First Approved Radioligand Therapy for Prostate Cancer
About Us ‘Telugu Times’ was started as the First Global Telugu Newspaper in USA in July 2003 by…